Placenta-derived Stem Cells May Help Sufferers Of Lung Diseases

Human placenta-derived stem cells, known to engraft in solid organs, including the lungs, also demonstrate characteristics of high plasticity and low immunogenicity. When transplanted into laboratory animals with bleomycin-induced lung fibrosis, fetal membrane cells were found to decrease lung fibrosis. Such transplantation may ultimately play a role in the treatment of lung diseases, such as pulmonary fibrosis and fibrotic diseases caused by tuberculosis, chemical exposure, radiation or pathogens. No known therapy reverses pulmonary fibrosis.

Read the whole article on Science Daily

More from Science Daily